Page last updated: 2024-08-21

propadiene and paclitaxel

propadiene has been researched along with paclitaxel in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, B; Chen, Y; Gu, H; Li, S; Liang, F; Wang, H; Wang, J; Yang, G; Yang, L	1

Other Studies

1 other study(ies) available for propadiene and paclitaxel

Article	Year
Analysis of the chemotherapeutic effects of a propadiene compound on malignant ovarian cancer cells. Oncotarget, 2016, Aug-30, Volume: 7, Issue:35 Topics: Alkadienes; Animals; Antineoplastic Agents; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 2; Cisplatin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Inhibitory Concentration 50; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Phosphatidylinositol 3-Kinases	2016

Article

Year

Analysis of the chemotherapeutic effects of a propadiene compound on malignant ovarian cancer cells.

Oncotarget, 2016, Aug-30, Volume: 7, Issue:35

Topics: Alkadienes; Animals; Antineoplastic Agents; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 2; Cisplatin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Inhibitory Concentration 50; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Phosphatidylinositol 3-Kinases

2016